Albany Molecular Research, Inc.
Curia is a global contract research, development, and manufacturing organization with over 30 years of experience. It offers services across drug discovery, development, manufacturing, and biologics, backed by scientific expertise and a global network of facilities. Curia aims to accelerate the delivery of therapies to patients through flexible, scalable solutions and a commitment to quality and innovation.
Industries
Nr. of Employees
Very Large (1000+)
Albany Molecular Research, Inc.
24 Corporate Circle, Albany, NY 12203, USA
Patents
Services
Hit‑to‑lead discovery services including assay development, in‑vitro biology, medicinal chemistry, structural biology and computational design.
Chemical process R&D, custom synthesis, high‑potency handling and GMP API production from kilograms to commercial scale.
Antibody discovery, single‑cell screening, developability assessment, recombinant antibody production and cell engineering to progress programs into development.
mRNA and self‑replicating RNA process development, analytical support and GMP production, and downstream formulation into lipid nanoparticle systems.
Formulation development, process development, clinical and commercial sterile fill–finish, lyophilization and packaging for parenteral products.
Method development and validation, batch release testing, stability studies and solid‑state chemistry to support regulatory submissions and product release.
Hit‑to‑lead discovery services including assay development, in‑vitro biology, medicinal chemistry, structural biology and computational design.
Chemical process R&D, custom synthesis, high‑potency handling and GMP API production from kilograms to commercial scale.
Antibody discovery, single‑cell screening, developability assessment, recombinant antibody production and cell engineering to progress programs into development.
mRNA and self‑replicating RNA process development, analytical support and GMP production, and downstream formulation into lipid nanoparticle systems.
Formulation development, process development, clinical and commercial sterile fill–finish, lyophilization and packaging for parenteral products.
Method development and validation, batch release testing, stability studies and solid‑state chemistry to support regulatory submissions and product release.
Expertise Areas
- Clinical manufacturing and sterile fill–finish
- Small‑molecule process development and API manufacturing
- Biologics discovery, cell‑line development and bioprocessing
- mRNA and long‑RNA (srRNA) development and manufacture
Key Technologies
- GMP manufacturing
- Isolator‑based vial filling and automated fill–finish lines
- Lyophilization (freeze‑drying)
- Lipid nanoparticle (LNP) formulation
News & Updates
Scheduled for July 21-23, 2025, in Boston, MA. Booth: 24.
AMRI was recognized in capabilities, compatibility, expertise, quality, reliability, and service based on small pharma respondents in primary market research.
Scheduled for July 21-23, 2025, in Boston, MA. Booth: 24.
AMRI was recognized in capabilities, compatibility, expertise, quality, reliability, and service based on small pharma respondents in primary market research.